Intra-Cellular Therapies, Inc. Underwriting Agreements

8 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated September 27, 2017, by and among the Company, J.P. Morgan Securities LLC and Leerink Partners LLC, as representatives of the several underwriters...
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2017
Underwriting Agreement, dated April 17, 2024, by and among the Company, J.P. Morgan Securities LLC, Leerink Partners LLC, BofA Securities, Inc., Morgan Stanley & Co. LLC and RBC...
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2024
Underwriting Agreement, dated January 4, 2022, by and among the Company, J.P. Morgan Securities LLC, SVB Leerink LLC, BofA Securities, Inc., Evercore Group L.L.C. and RBC Capital...
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2022
Underwriting Agreement, dated September 10, 2020, by and among the Company, J.P. Morgan Securities LLC, Goldman Sachs & Co. LLC, and SVB Leerink LLC, as representatives of the...
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2020
Underwriting Agreement, dated January 7, 2020, by and among the Company, J.P. Morgan Securities LLC and SVB Leerink LLC, as representatives of the several underwriters named...
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2020
INTRA-CELLULAR THERAPIES, INC. 7,935,000 Shares of Common Stock (Including 1,035,000 Option Shares) Underwriting Agreement
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2015
INTRA-CELLULAR THERAPIES, INC. 5,462,500 Shares of Common Stock (Including 712,500 Option Shares) Underwriting Agreement
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2015
INTRA-CELLULAR THERAPIES, INC. Shares of Common Stock Underwriting Agreement
Underwriting Agreements
Intra-Cellular Therapies, Inc.
Pharmaceuticals
NY
2014